Advances in Formulation of Nanocarriers for Overcoming Biological Barriers
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (30 April 2025) | Viewed by 1515
Special Issue Editor
Special Issue Information
Dear Colleagues,
Nanocarriers have shown a considerable advantage in increasing the biological performance of drugs, revolutionizing nanomedicine. For their application, nanocarriers should be transported by the human body, overcoming physiological barriers, such as mucosal, epithelial, or intracellular, to achieve precision drug delivery.
To design nanocarriers we should consider not only physiological barriers but also the pathological state, which restructures tissue properties, such as inflammation or the tumor microenvironment, demanding new strategies for drug targeting in this modified biophase.
Therefore, in this Special Issue, we plan to collect the latest advances in new nanocarriers, aiming to overcome the physiological/pathological barriers and to describe their formulation, pharmacokinetics, toxicology, and biological targets.
Dr. Sandra Elisa Haas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biological barriers
- drug delivery
- nanocarriers
- pharmacokinetics
- toxicology
- pharmacodynamics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
